These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17918127)

  • 1. Staphylococcus biofilm components as targets for vaccines and drugs.
    Visai L; Arciola CR; Pietrocola G; Rindi S; Olivero P; Speziale P
    Int J Artif Organs; 2007 Sep; 30(9):813-9. PubMed ID: 17918127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quorum-sensing control in Staphylococci -- a target for antimicrobial drug therapy?
    Otto M
    FEMS Microbiol Lett; 2004 Dec; 241(2):135-41. PubMed ID: 15598524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches for treating staphylococcal biofilm infections.
    Kiedrowski MR; Horswill AR
    Ann N Y Acad Sci; 2011 Dec; 1241():104-21. PubMed ID: 22191529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fighting Staphylococcus aureus Biofilms with Monoclonal Antibodies.
    Raafat D; Otto M; Reppschläger K; Iqbal J; Holtfreter S
    Trends Microbiol; 2019 Apr; 27(4):303-322. PubMed ID: 30665698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
    Kokai-Kun JF; Chanturiya T; Mond JJ
    J Antimicrob Chemother; 2009 Jul; 64(1):94-100. PubMed ID: 19398455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Analyses on Data including Essential Oil Chemical Composition and In Vitro Experimental Antibiofilm Activities against
    Patsilinakos A; Artini M; Papa R; Sabatino M; Božović M; Garzoli S; Vrenna G; Buzzi R; Manfredini S; Selan L; Ragno R
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30832446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies.
    Schilcher K; Horswill AR
    Microbiol Mol Biol Rev; 2020 Aug; 84(3):. PubMed ID: 32792334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future approaches to the prevention and treatment of staphylococcal medical device-related infections.
    Hogan S; Stevens NT; Humphreys H; O'Gara JP; O'Neill E
    Curr Pharm Des; 2015; 21(1):100-13. PubMed ID: 25189861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-biofilm agents: recent breakthrough against multi-drug resistant Staphylococcus aureus.
    Chung PY; Toh YS
    Pathog Dis; 2014 Apr; 70(3):231-9. PubMed ID: 24453168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quorum-sensing systems in staphylococci as therapeutic targets.
    Harraghy N; Kerdudou S; Herrmann M
    Anal Bioanal Chem; 2007 Jan; 387(2):437-44. PubMed ID: 17072597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
    Balaban N; Giacometti A; Cirioni O; Gov Y; Ghiselli R; Mocchegiani F; Viticchi C; Del Prete MS; Saba V; Scalise G; Dell'Acqua G
    J Infect Dis; 2003 Feb; 187(4):625-30. PubMed ID: 12599079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel hamamelitannin analogues as potentiators for vancomycin in the treatment of biofilm related Staphylococcus aureus infections.
    Vermote A; Brackman G; Risseeuw MDP; Coenye T; Van Calenbergh S
    Bioorg Med Chem; 2016 Oct; 24(19):4563-4575. PubMed ID: 27507109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal Vaccine Antigens related to biofilm formation.
    Mirzaei B; Babaei R; Valinejad S
    Hum Vaccin Immunother; 2021 Jan; 17(1):293-303. PubMed ID: 32498595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.
    Mihu MR; Cabral V; Pattabhi R; Tar MT; Davies KP; Friedman AJ; Martinez LR; Nosanchuk JD
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors.
    Kiran MD; Giacometti A; Cirioni O; Balaban N
    Int J Artif Organs; 2008 Sep; 31(9):761-70. PubMed ID: 18924087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes.
    Donelli G; Francolini I; Romoli D; Guaglianone E; Piozzi A; Ragunath C; Kaplan JB
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2733-40. PubMed ID: 17548491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of Staphylococcus aureus biofilms.
    Bhattacharya M; Wozniak DJ; Stoodley P; Hall-Stoodley L
    Expert Rev Anti Infect Ther; 2015; 13(12):1499-516. PubMed ID: 26646248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms.
    Suresh MK; Biswas R; Biswas L
    Int J Med Microbiol; 2019 Jan; 309(1):1-12. PubMed ID: 30503373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm formation in medical device-related infection.
    Mack D; Rohde H; Harris LG; Davies AP; Horstkotte MA; Knobloch JK
    Int J Artif Organs; 2006 Apr; 29(4):343-59. PubMed ID: 16705603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of DispersinB on methicillin-resistant Staphylococcus pseudintermedius biofilm.
    Turk R; Singh A; Rousseau J; Weese JS
    Vet Microbiol; 2013 Oct; 166(3-4):576-9. PubMed ID: 23932310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.